Daniel Águila‐Gordo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Daniel Águila‐Gordo has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Cristina Ruiz‐Pastor
Medicine Faculty Castilla La‐Mancha University Ciudad Real Spain
1 shared publicationIgnacio Sánchez Pérez
Hemodynamics and Interventional Cardiology Unit, Cardiology Department Hospital General Universitario de Ciudad Real Ciudad Real Spain
1 shared publication- Javier Jiménez-Díaz
Arrhythmia Unit, Cardiology Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain
1 shared publication - Jesús Piqueras-Flores
Inherited Heart Disease and Heart Failure Unit, Cardiology Department, General University Hospital of Ciudad Real Faculty of Medicine, University of Castilla La Mancha IDISCAM, Biomedical Research Institute of Castilla La Mancha, Spain (J.P.-F.).
1 shared publication Jorge Martínez‐Del Rio
Cardiology Department Hospital General Universitario de Ciudad Real Ciudad Real Spain
1 shared publicationMartín Negreira‐Caamaño
Cardiology Department Hospital General Universitario de Ciudad Real Ciudad Real Spain
1 shared publication
Latest Publications
- Open Access
- 20 November 2023
- Published by Wiley in Annals of Noninvasive Electrocardiology
- Vol. 29 (1) , e13095
Usefulness of risk scores and predictors of atrial fibrillation recurrence after elective electrical cardioversion
Introduction: Electrical cardioversion (ECV) is a frequently used procedure for restoring sinus rhythm in atrial fibrillation (AF); however, the rate of recurrence is high. The identification of patients at high risk of recurrence could influence the decision‐making process. The present study evaluates the predictive value of risk scores in atrial fibrillation recurrence after elective electrical cardioversion.Methods: Unicentric, observational, and prospective study of adult patients who have undergone an elective ECV as rhythm control strategy between July 2017 and September 2022.Results: From the 283 analyzed patients (mean age 63.95 ± 10.76212, 74.9% male); 99 had paroxysmal AF (35%) and 159 (59%) presented AF recurrence during a follow‐up of 6 months. In patients with post‐ECV AF recurrence, the period of time from diagnosis until the performance of the procedure was longer (393 ± 891 vs. 195 ± 527, p = .02). No paroxysmal AF (71.3% vs. 57.8%, p = .02) and LA dilatation with >40 mL/m2 (35.9% vs. 23.3%, p = .02) volumes were more frequent within these patients. AF recurrence was more frequent in patients who had previous ECV (HR = 1.32; 95% CI: 1.12–2.35; p = .01) and more than 1 shock to recover sinus rhythm (HR = 1.62; 95% CI: 1.07–1.63; p = .01). The SLAC, ALARMEc, ATLAS, and CAAP‐AF scores were statistically significant, although with a moderate predictive capacity for post‐ECV recurrence.Conclusions: Risk scores analyzed showed a modest value predicting AF recurrence after ECV. Previous ECV, and greater difficulty in restoring SR were independent predictors of recurrence.
- 20 November 2023
- Published by Wiley in Annals of Noninvasive Electrocardiology
- Vol. 29 (1) , e13095
Open AccessUsefulness of risk scores and predictors of atrial fibrillation recurrence after elective electrical cardioversion
Introduction: Electrical cardioversion (ECV) is a frequently used procedure for restoring sinus rhythm in atrial fibrillation (AF); however, the rate of recurrence is high. The identification of patients at high risk of recurrence could influence the decision‐making process. The present study evaluates the predictive value of risk scores in atrial fibrillation recurrence after elective electrical cardioversion.Methods: Unicentric, observational, and prospective study of adult patients who have undergone an elective ECV as rhythm control strategy between July 2017 and September 2022.Results: From the 283 analyzed patients (mean age 63.95 ± 10.76212, 74.9% male); 99 had paroxysmal AF (35%) and 159 (59%) presented AF recurrence during a follow‐up of 6 months. In patients with post‐ECV AF recurrence, the period of time from diagnosis until the performance of the procedure was longer (393 ± 891 vs. 195 ± 527, p = .02). No paroxysmal AF (71.3% vs. 57.8%, p = .02) and LA dilatation with >40 mL/m2 (35.9% vs. 23.3%, p = .02) volumes were more frequent within these patients. AF recurrence was more frequent in patients who had previous ECV (HR = 1.32; 95% CI: 1.12–2.35; p = .01) and more than 1 shock to recover sinus rhythm (HR = 1.62; 95% CI: 1.07–1.63; p = .01). The SLAC, ALARMEc, ATLAS, and CAAP‐AF scores were statistically significant, although with a moderate predictive capacity for post‐ECV recurrence.Conclusions: Risk scores analyzed showed a modest value predicting AF recurrence after ECV. Previous ECV, and greater difficulty in restoring SR were independent predictors of recurrence.